Your browser doesn't support javascript.
loading
Dual-targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn's disease.
Vernero, Marta; Ribaldone, Davide Giuseppe; Cariti, Caterina; Ribero, Simone; Susca, Sara; Astegiano, Marco; Dapavo, Paolo.
Afiliação
  • Vernero M; First Department of Internal Medicine, University of Pavia, Pavia, Italy.
  • Ribaldone DG; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Cariti C; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
  • Ribero S; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
  • Susca S; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
  • Astegiano M; Unit of Gastroenterology, Molinette Hospital, Turin, Italy.
  • Dapavo P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
J Dermatol ; 47(6): e216-e217, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32347562
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Doença de Crohn / Pioderma Gangrenoso / Anticorpos Monoclonais Humanizados Tipo de estudo: Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Doença de Crohn / Pioderma Gangrenoso / Anticorpos Monoclonais Humanizados Tipo de estudo: Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article